156. レット症候群
[臨床試験数:36,薬物数:49(DrugBank:19),標的遺伝子数:77,標的パスウェイ数:112

Searched query = "Rett syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01777542
(ClinicalTrials.gov)
January 201323/1/2013Treatment of Rett Syndrome With Recombinant Human IGF-1Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)Rett SyndromeDrug: Recombinant Human Insulin Growth Factor 1 (rhIGF-1);Drug: PlaceboBoston Children's HospitalInternational Rett Syndrome FoundationCompleted2 Years10 YearsFemale30Phase 2United States